Pages that link to "Q34428000"

The following pages link to Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer (Q34428000):

Displaying 15 items.

• Targeted drugs in small-cell lung cancer (Q26767017) (← links)
• Origins, genetic landscape, and emerging therapies of small cell lung cancer (Q26798218) (← links)
• The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma (Q26827928) (← links)
• Targeted therapies in small cell lung cancer: a review (Q35076234) (← links)
• Novel therapeutic approaches for small cell lung cancer: the future has arrived (Q36084288) (← links)
• BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis (Q36284637) (← links)
• Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. (Q38563530) (← links)
• Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope (Q39393217) (← links)
• Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation (Q39508374) (← links)
• The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum. (Q40222201) (← links)
• Endoplasmic reticulum stress-mediated autophagy protects against β,β-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells. (Q55220293) (← links)
• Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers (Q57147999) (← links)
• Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review (Q91724678) (← links)
• Substrate Flexibility of the Flavin-Dependent Dihydropyrrole Oxidases PigB and HapB Involved in Antibiotic Prodigiosin Biosynthesis (Q92748392) (← links)
• Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer (Q101166360) (← links)